ArticleMolecular oncology2023

mFast-SeqS-based aneuploidy score in circulating cell-free DNA is a prognostic biomarker in prostate cancer.

Khrystany T Isebia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.